Skip to main content

Table 1 Demographic and clinical characteristics of patients treated with vancomycin

From: Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible

Variables

Numbers (%)

Total patients

228 (100)

Age groups

 Group -I: children of age 3–6 months

45 (19.7)

 Group -II: children of > 6 month–2 years

70 (30.7)

 Group -III: children of > 2 to 6 years

55 (24.1)

 Group -IV: children of > 6 to 12 years

58 (25.4)

Gender

 Female

82 (35.9%)

 Male

146 (64.1%)

System involved in illness/primary diagnosis /diagnosis at admission

 CNS

21 (9.2%)

 Bone and soft tissues

6 (2.6%)

 Cardiac

21 (9.2%)

 Colostomy

3 (1.3%)

 Congenital heart disease

0 (0.0%)

 Gastrointestinal

27 (11.8%)

 Hematological

6 (2.6%)

 Hepatic

3 (1.3%)

 Metabolic disorder

12 (5.3%)

 Respiratory

57 (25.0%)

 Bones and soft tissues

12 (5.3%)

 Soft tissue

3 (1.3%)

 Sepsis

57 (25.0%)

Unit of care/Service department

 Pediatric ICU

30 (13.2%)

 Pediatric-Medicine

162 (71.1%)

 Pediatric-Surgery

36 (15.8%)

Confirmed infection

 No

78 (34.2%)

 Yes

150 (65.8%)